Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Blog
Podcast
Product Guide
Career Quest
Clinical Trial Alert
Blog Post
Clinical Trial Alert: Phase 3 Study of Inebilizumab in Adults with Myasthenia Gravis
By
Sujatha Gurunathan
|
October 24, 2022
Blog Post
Clinical Trial Alert: Phase 3 Study of IgPro20 in Adults with Dermatomyositis
By
Sujatha Gurunathan
|
August 17, 2022
Blog Post
Clinical Trial Alert: Phase 2 Study of Oral Ifetroban in Individuals with DMD
By
Sujatha Gurunathan
|
August 10, 2022
Blog Post
Clinical Trial Alert: Phase 3 Study of investigational drug in Adults Living with ALS
By
Sujatha Gurunathan
|
May 17, 2022
Blog Post
Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults Living with gMG
By
MDA Staff
|
April 6, 2022
Blog Post
Clinical Trial Alert: Phase 2 Study of Ravulizumab (Ultomiris) in Adults Living with Dermatomyositis
By
MDA Staff
|
April 5, 2022
Blog Post
Clinical Trial Alert: Phase 1b/2a Study of WVE-N531 in a Subset of People Living with DMD
By
Sujatha Gurunathan
|
March 11, 2022
Blog Post
Clinical Trial Alert: Early Phase Study of SRP-9001 in Boys with DMD
By
Sujatha Gurunathan
|
November 9, 2021
Blog Post
Clinical Trial Alert: Phase 2/3 Study of Tideglusib (AMO-02) in Children and Adolescents with Congenital Myotonic Dystrophy
By
Sujatha Gurunathan
|
November 9, 2021
Blog Post
Clinical Trial Alert: Phase 3b Study of Oral Edaravone in Adults with ALS
By
Sujatha Gurunathan
|
October 11, 2021
« Previous
1
2
3
4
5
6
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
